Claus Bachert

Claus Bachert

Universiteit Gent

H-index: 146

Europe-Belgium

About Claus Bachert

Claus Bachert, With an exceptional h-index of 146 and a recent h-index of 102 (since 2020), a distinguished researcher at Universiteit Gent,

His recent articles reflect a diverse array of research interests and contributions to the field:

Monitoring mepolizumab treatment in chronic rhinosinusitis with nasal polyps (CRSwNP): Discontinue, change, continue therapy?

Chronic rhinosinusitis with nasal polyps (CRSwNP) treated with omalizumab, dupilumab, or mepolizumab: a systematic review of the current knowledge towards an attempt to compare …

Dupilumab Reduces Asthma Disease Burden and Recurrent SCS Use in Patients with CRSwNP and Coexisting Asthma

Reviews and feature articles

Prevalence of type 2 inflammatory signatures and efficacy of dupilumab in patients with chronic rhinosinusitis with nasal polyps from two phase 3 clinical trials: SINUS‐24 and …

Evaluation of ongoing mepolizumab treatment in chronic rhinosinusitis with nasal polyps

Endoskopisches Scoring von Nasenpolypen: Executive Summary des EAACI-Positionspapiers

Impact of Mepolizumab on Sleep Disturbance in Patients With Chronic Rhinosinusitis With Nasal Polyps and/or Asthma: Analysis From SYNAPSE and MUSCA

Claus Bachert Information

University

Position

Buitengewoon hoogleraar

Citations(all)

100140

Citations(since 2020)

46158

Cited By

71033

hIndex(all)

146

hIndex(since 2020)

102

i10Index(all)

645

i10Index(since 2020)

511

Email

University Profile Page

Google Scholar

Top articles of Claus Bachert

Monitoring mepolizumab treatment in chronic rhinosinusitis with nasal polyps (CRSwNP): Discontinue, change, continue therapy?

2024

Orlando Guntinas-Lichius
Orlando Guntinas-Lichius

H-Index: 37

Claus Bachert
Claus Bachert

H-Index: 85

Chronic rhinosinusitis with nasal polyps (CRSwNP) treated with omalizumab, dupilumab, or mepolizumab: a systematic review of the current knowledge towards an attempt to compare …

2024/1

Nan Zhang
Nan Zhang

H-Index: 10

Claus Bachert
Claus Bachert

H-Index: 85

Dupilumab Reduces Asthma Disease Burden and Recurrent SCS Use in Patients with CRSwNP and Coexisting Asthma

Journal of Asthma and Allergy

2024/12/31

Claus Bachert
Claus Bachert

H-Index: 85

Seong H Cho
Seong H Cho

H-Index: 21

Prevalence of type 2 inflammatory signatures and efficacy of dupilumab in patients with chronic rhinosinusitis with nasal polyps from two phase 3 clinical trials: SINUS‐24 and …

International forum of allergy & rhinology

2024/3

Claus Bachert
Claus Bachert

H-Index: 85

Evaluation of ongoing mepolizumab treatment in chronic rhinosinusitis with nasal polyps

2024/2/22

Orlando Guntinas-Lichius
Orlando Guntinas-Lichius

H-Index: 37

Claus Bachert
Claus Bachert

H-Index: 85

Endoskopisches Scoring von Nasenpolypen: Executive Summary des EAACI-Positionspapiers

HNO Nachrichten

2024/2

Claus Bachert
Claus Bachert

H-Index: 85

Impact of Mepolizumab on Sleep Disturbance in Patients With Chronic Rhinosinusitis With Nasal Polyps and/or Asthma: Analysis From SYNAPSE and MUSCA

Journal of Allergy and Clinical Immunology

2024/2/1

MZB1-expressing cells are essential for local immunoglobulin production in chronic rhinosinusitis with nasal polyps

Annals of Allergy, Asthma & Immunology

2024/2/1

Associations of tenascin C with Th2 response, edema degree, and disease severity in patients with chronic rhinosinusitis with nasal polyps

Allergy

2024/1/17

Choice of surgery in intestinal-type adenocarcinoma of the sinonasal tract: a long-term comparative study

European Archives of Oto-Rhino-Laryngology

2024/1/16

Wouter Huvenne
Wouter Huvenne

H-Index: 14

Claus Bachert
Claus Bachert

H-Index: 85

Dupilumab zeigt Wirksamkeit bei Patienten mit chronischer Rhinosinusitis mit Nasenpolypen und Typ-2-Inflammatorischen Signaturen unabhängig von deren Definition

Laryngo-Rhino-Otologie

2023/5

Claus Bachert
Claus Bachert

H-Index: 85

Respiratory virome profiles reflect antiviral immune responses

Allergy

2023/5

Clinical efficacy among patients with chronic rhinosinusitis with nasal polyps and clinical features of obstructive lung disease: post hoc analysis of the Phase III SINUS-24 …

Journal of Asthma and Allergy

2023/12/31

Claus Bachert
Claus Bachert

H-Index: 85

Differential protease content of mast cells and the processing of IL-33 in Alternaria alternata induced allergic airway inflammation in mice

Frontiers in immunology

2023/4/19

Evaluating treatment responses of dupilumab versus omalizumab in severe chronic rhinosinusitis with nasal polyps and comorbid asthma patients: The Everest trial

Journal of Allergy and Clinical Immunology

2022/2/1

Obituary: Jörg Kleine-Tebbe

Allergy

2023/4

Claus Bachert
Claus Bachert

H-Index: 85

Effect of Dupilumab on type 2 biomarkers in chronic rhinosinusitis with nasal polyps: SINUS-52 study results

Annals of Otology, Rhinology & Laryngology

2023/12

Claus Bachert
Claus Bachert

H-Index: 85

Seong H Cho
Seong H Cho

H-Index: 21

DUPILUMAB IMPROVES OLFACTION IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPS IRRESPECTIVE OF GENDER

Annals of Allergy, Asthma & Immunology

2023/11/1

European Academy of Allergy and Clinical Immunology position paper on endoscopic scoring of nasal polyposis

Pediatr Allergy Immunol

2021/7/29

See List of Professors in Claus Bachert University(Universiteit Gent)